InfuSystem Holdings, Inc.
General ticker "INFU" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $189.0M (TTM average)
InfuSystem Holdings, Inc. follows the US Stock Market performance with the rate: 44.8%.
Estimated limits based on current volatility of 1.7%: low 13.48$, high 13.94$
Factors to consider:
- Total employees count: 473 (-8.0%) as of 2025
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: Reimbursement changes, Fulfillment and delivery delays, Billing audits and reviews, Market competition, Product defects
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [8.46$, 13.63$]
- 2026-12-31 to 2027-12-31 estimated range: [9.65$, 15.26$]
Financial Metrics affecting the INFU estimates:
- Positive: with PPE of 28.2 at the end of fiscal year the price was neutral
- Positive: 11.37 < Operating cash flow per share per price, % of 13.11
- Positive: 7.80 < Operating profit margin, % of 8.31
- Positive: Interest expense per share per price, % of 0.70 <= 0.75
- Positive: 5.14 < Return on assets ratio (scaled to [-100,100]) of 6.18
- Positive: 0.90 < Industry operating cash flow per share per price (median), % of 1.58
- Positive: -4.49 < Investing cash flow per share per price, % of -3.65
Short-term INFU quotes
Long-term INFU plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $125.78MM | $134.86MM | $143.44MM |
| Operating Expenses | $121.70MM | $127.97MM | $131.52MM |
| Operating Income | $4.09MM | $6.89MM | $11.92MM |
| Non-Operating Income | $-2.24MM | $-1.83MM | $-1.30MM |
| Interest Expense | $2.17MM | $1.78MM | $1.30MM |
| Income(Loss) | $1.85MM | $5.06MM | $10.62MM |
| Taxes | $0.98MM | $2.71MM | $4.00MM |
| Net Income(Loss)* | $0.87MM | $2.35MM | $6.63MM |
| Stockholders Equity | $52.30MM | $57.53MM | $57.33MM |
| Inventory | $6.40MM | $6.53MM | $5.39MM |
| Assets | $102.92MM | $103.61MM | $100.56MM |
| Operating Cash Flow | $11.22MM | $20.46MM | $24.41MM |
| Capital expenditure | $11.12MM | $17.83MM | $8.69MM |
| Investing Cash Flow | $-6.73MM | $-13.24MM | $-6.79MM |
| Financing Cash Flow | $-4.42MM | $-6.92MM | $-14.96MM |
| Earnings Per Share** | $0.04 | $0.11 | $0.32 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.